This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 April 2023 and includes updates on influenza, Marburg virus disease, COVID-19, MERS-CoV, Measles and diphtheria.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 April 2023 and includes updates on mpox, Group A streptococcal, Influenza A(H5N1) infection, and Marburg virus disease.
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe disease in humans caused by Marburg marburgvirus (MARV). Although MVD is uncommon, MARV has the potential to cause epidemics with significant case fatality rates.
Since late February 2023 and up until 30 March 2023, 87 cases of botulism linked to intragastric injection of the botulinum neurotoxin (BoNT) have been reported.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 March - 1 April 2023 and includes updates on Iatrogenic botulism exposure in Türkiye, COVID-19, group A streptococcal infection, influenza, swine influenza. Marburg virus disease and poliomyelitis.
This literature review, covering the period from 2000 to January 2022, assessed the state of knowledge on biocide resistance in wild vector populations across the EU/EEA and neighbouring countries.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A streptococcal infection, influenza, chikungunya and dengue, and influenza B among young people.